BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Saturday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of BIOL opened at $0.01 on Friday. BIOLASE has a one year low of $0.02 and a one year high of $1.94. The company has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.03. The stock has a market cap of $315,696.15, a price-to-earnings ratio of 0.00 and a beta of 0.67.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.